Concepedia
Statistics
Publications
22
Citations
1.8K
H-Index
19
Active since
2004
Affiliations
Massachusetts General Hospital(Current)
Harvard University
Center for Cancer Research
The University of Texas Southwestern Medical Center
Broad Institute
Lei Shi is an author at Massachusetts General Hospital specializing in molecular biology, life sciences, and oncology.
Publications per year
2004–2025
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma
Lipika Goyal, Lei Shi, Leah Y. Liu et al. · Cancer Discovery · 2019 · 371 citations · Full text
Medicine, Oncology, Pharmacology +17
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma
Supriya K. Saha, John D. Gordan, Benjamin P. Kleinstiver et al. · Cancer Discovery · 2016 · 163 citations
Medicine, Molecular Biology, Oncology +17
Trehalose Is a Key Determinant of the Quiescent Metabolic State That Fuels Cell Cycle Progression upon Return to Growth
Lei Shi, Benjamin M. Sutter, Xinyue Ye et al. · Molecular Biology of the Cell · 2010 · 145 citations · Full text
Life Sciences, Biology, Microbiology +17
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
Tommy Weiss‐Sadan, Maolin Ge, Makiko Hayashi et al. · Cell Metabolism · 2023 · 144 citations · Full text
Life Sciences, Cell Biology, Oncology +16
Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway
Junbing Zhang, Claire Simpson, Jacqueline Berner et al. · Cell · 2023 · 142 citations · Full text
Life Sciences, Cancer Biology, Oncology +15
1–5 of 22